Founded in 2010, Advanced BioDesign is a clinical stage company developing a highly promising therapy for cancer with high unmet medical needs. Advanced Biodesign has developed a therapeutic approach based on a selective inhibition of ALDH enzymes.
Advanced Biodesign project consist in the development of small-molecule that will selectively inhibit specific ALDH enzyme. By targeting this family of enzyme, will block specifically the intracellular mechanism of detoxification that cancerous cells have developed in order to escape form the programmed cell death called apoptosis.
Location: France, Auvergne-Rhône-Alpes, Saint-Priest
Member count: 11-50
Total raised: $9.791868M
Founded date: 2010
Investors 1
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 25.02.2020 | - | $9.791868M | - | finsmes.co... |
Mentions in press and media 1
| Date | Title | Description | Category | Author | Source |
| 25.02.2020 | Advanced B... | Advanced BioDesign, a Lyon, Fr... | France | - | finsmes.co... |